OMAHA, Neb., May 12, 2011 /PRNewswire/ — Transgenomic,
Inc. (OTC/BB: TBIO) today announced the following
Webcast:What:
Transgenomic, Inc. First Quarter 2011 Financial Results and
Business Update Conference CallWhen:
Thursday, May 12, 2011 @ 5:00 p.m. EasternWhere:
http://www.transgenomic.com/events.asp?id=6How:
Live over the Internet — Simply log on to the web at the
address above.Contact:
Investor Relations, 402-452-5400 To access the call via
telephone, call 800-895-0198 from the U.S. or Canada or
785-424-1053 for international participants and enter conference ID
TRANS. A telephone replay will be available from 6:00 p.m.
Eastern Time May 12, 2011 through 11:59 p.m. Eastern Time on May
26, 2011 by dialing 800-374-0328 (domestic) or 402-220-0663
(international).
About Transgenomic, Inc.Transgenomic, Inc. (www.transgenomic.com) is a
global biotechnology company specializing in high sensitivity
genetic variation and mutation analysis, providing products and
services in DNA mutation detection and discovery for clinical
research, clinical molecular diagnostics and pharmacogenomic
analyses. Transgenomic, Inc. is comprised of 3 different
divisions. Transgenomic Molecular Lab specializes in
molecular diagnostics for cardiology, neurology, mitochondrial
disorders, oncology, hematology, molecular pathology and other
inherited diseases. Transgenomic Pharmacogenomic Services is
a contract research service offering translational research and
clinical trial services to pharmaceutical companies in support of
pre-clinical and phase I, II and III clinical trials.
Transgenomic’s Diagnostic Tools Business product offerings
include systems for the automation of sample processing and
analysis for Cytogenetic and Molecular Diagnostic testing.
Transgenomic’s WAVE® Systems and associated con
‘/>”/>
SOURCE